Discovery of<i>Tirasemtiv</i>, the First Direct Fast Skeletal Muscle Troponin Activator

Scott E. Collibee(Cytokinetics (United States)), Gustave Bergnes(Cytokinetics (United States)), Alexander R. Muci(Cytokinetics (United States)), William F. Browne(Cytokinetics (United States)), Marc Garard(Cytokinetics (United States)), Aaron C. Hinken(Cytokinetics (United States)), Alan J. Russell(Cytokinetics (United States)), Ion Suehiro(Cytokinetics (United States)), James J. Hartman(Cytokinetics (United States)), Raja Kawas(Cytokinetics (United States)), Pu‐Ping Lu(Cytokinetics (United States)), Kenneth Lee(Cytokinetics (United States)), David X. Márquez(Cytokinetics (United States)), Matthew Tomlinson(Cytokinetics (United States)), Donghong Xu(Cytokinetics (United States)), Adam Kennedy(Cytokinetics (United States)), Darren T. Hwee(Cytokinetics (United States)), Julia Schaletzky(Cytokinetics (United States)), Kwan Leung(Cytokinetics (United States)), Fady I. Malik(Cytokinetics (United States)), David J. Morgans(Cytokinetics (United States)), B. Paul Morgan(Cytokinetics (United States))
ACS Medicinal Chemistry Letters
February 13, 2018
Cited by 29Open Access
Full Text

Abstract

), which has been extensively characterized in clinical trials for the treatment of amyotrophic lateral sclerosis.


Related Papers

No related papers found

Powered by citation graph analysis